{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:08:40Z","timestamp":1778522920918,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ijantimicag.2004.12.001","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T12:11:39Z","timestamp":1110024699000},"page":"282-289","source":"Crossref","is-referenced-by-count":20,"title":["Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002\u20132003): contemporary in vitro activities of amoxicillin\/clavulanate and 15 other antimicrobial agents"],"prefix":"10.1016","volume":"25","author":[{"given":"Sudha","family":"Pottumarthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew G.","family":"Stilwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2004.12.001_bib1","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nm839","article-title":"Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States","volume":"9","author":"McCormick","year":"2003","journal-title":"Nature Med"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib3","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1086\/382696","article-title":"Antibiotic resistance in Streptococcus pneumoniae: what does the future hold?","volume":"38","author":"Neurmberger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1542\/peds.113.3.443","article-title":"Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine","volume":"113","author":"Kaplan","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib5","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1086\/380488","article-title":"Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib6","unstructured":"GlaxoSmithKline Prescribing information for Augmentin ES-600\u00ae. Available from URL: http:\/\/us.gsk.com\/products\/assets\/us_augmentin_es600.pdf. AE:L9. GSK, Research Triangle Park, NC 27709, 2004."},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib7","unstructured":"GlaxoSmithKline Prescribing information for Augmentin XR\u2122 Available from URL: http:\/\/us.gsk.com\/products\/assets\/us_augmentin_xr.pdf. AX:L6. GSK, Research Triangle Park, NC 27709, 2004."},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkh050","article-title":"Augmentin\u00ae (amoxicillin\/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent","volume":"53","author":"White","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0732-8893(03)00087-7","article-title":"Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program","volume":"46","author":"Gordon","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/374052","article-title":"Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998\u20132002)","volume":"36","author":"Karlowsky","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib11","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6. Wayne, PA: NCCLS; 2003."},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib12","unstructured":"National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 14th informational supplement M100-S14. Wayne, PA: NCCLS; 2004."},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada","volume":"341","author":"Chen","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jac\/dkg321","article-title":"The Alexander Project 1998\u20132000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents","volume":"52","author":"Jacobs","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib15","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-199901000-00002","article-title":"Acute otitis media: management and surveillance in the era of pneumococcal resistance \u2014 a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group","volume":"18","author":"Dowell","year":"1999","journal-title":"Ped Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3201\/eid1003.030252","article-title":"Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes","volume":"10","author":"Albrich","year":"2004","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.diagmicrobio.2004.02.005","article-title":"Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999\u20132002)","volume":"49","author":"Jones","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10096-004-1133-5","article-title":"Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine and skin and soft tissue infections in pediatric patients","volume":"23","author":"Jones","year":"2004","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0732-8893(03)00015-4","article-title":"Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America, (2000\u20132001): report from the SENTRY Antimicrobial Surveillance Program","volume":"46","author":"Jones","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib21","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1128\/AAC.47.6.1790-1797.2003","article-title":"Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis clinical isolates from children: results from 2000\u20132001 and 2001\u20132002 TRUST studies in the United States","volume":"47","author":"Karlowsky","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2004.12.001_bib22","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1016\/S0002-9343(01)01025-7","article-title":"Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the Respiratory Surveillance Program Study: microbiology from the medical office practice environment","volume":"111","author":"Pfaller","year":"2001","journal-title":"Am J Med"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857905000105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T09:51:14Z","timestamp":1548669074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857905000105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0924857905000105"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2004.12.001","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}